Cubist Systematic Strategies’s Revance Therapeutics, Inc. RVNC Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-293,675
| Closed | -$893K | – | 2443 |
|
2024
Q4 | $893K | Buy |
293,675
+63,066
| +27% | +$192K | 0.01% | 838 |
|
2024
Q3 | $1.2M | Buy |
+230,609
| New | +$1.2M | 0.01% | 760 |
|
2024
Q2 | – | Sell |
-35,521
| Closed | -$175K | – | 2788 |
|
2024
Q1 | $175K | Sell |
35,521
-269,926
| -88% | -$1.33M | ﹤0.01% | 1712 |
|
2023
Q4 | $2.68M | Buy |
305,447
+85,234
| +39% | +$749K | 0.02% | 693 |
|
2023
Q3 | $2.53M | Sell |
220,213
-40,594
| -16% | -$466K | 0.02% | 697 |
|
2023
Q2 | $6.6M | Buy |
260,807
+87,121
| +50% | +$2.21M | 0.04% | 399 |
|
2023
Q1 | $5.59M | Sell |
173,686
-109,141
| -39% | -$3.52M | 0.03% | 538 |
|
2022
Q4 | $5.22M | Buy |
282,827
+176,199
| +165% | +$3.25M | 0.03% | 658 |
|
2022
Q3 | $2.88M | Sell |
106,628
-138,584
| -57% | -$3.74M | 0.02% | 1284 |
|
2022
Q2 | $3.39M | Buy |
245,212
+221,707
| +943% | +$3.06M | 0.02% | 1119 |
|
2022
Q1 | $458K | Sell |
23,505
-32,001
| -58% | -$624K | ﹤0.01% | 2567 |
|
2021
Q4 | $906K | Buy |
55,506
+35,608
| +179% | +$581K | 0.01% | 1987 |
|
2021
Q3 | $554K | Sell |
19,898
-14,800
| -43% | -$412K | 0.01% | 1962 |
|
2021
Q2 | $1.03M | Buy |
34,698
+27,008
| +351% | +$800K | 0.01% | 1554 |
|
2021
Q1 | $215K | Buy |
+7,690
| New | +$215K | ﹤0.01% | 2423 |
|
2020
Q4 | – | Sell |
-34,052
| Closed | -$856K | – | 2744 |
|
2020
Q3 | $856K | Buy |
+34,052
| New | +$856K | 0.01% | 1428 |
|
2020
Q2 | – | Sell |
-108,435
| Closed | -$1.61M | – | 2554 |
|
2020
Q1 | $1.61M | Buy |
108,435
+62,350
| +135% | +$923K | 0.04% | 569 |
|
2019
Q4 | $748K | Buy |
+46,085
| New | +$748K | 0.01% | 1336 |
|
2019
Q3 | – | Sell |
-35,982
| Closed | -$467K | – | 2538 |
|
2019
Q2 | $467K | Buy |
35,982
+471
| +1% | +$6.11K | 0.01% | 1521 |
|
2019
Q1 | $560K | Buy |
+35,511
| New | +$560K | 0.02% | 1115 |
|
2018
Q3 | – | Sell |
-8,795
| Closed | -$241K | – | 2106 |
|
2018
Q2 | $241K | Buy |
8,795
+2,654
| +43% | +$72.7K | 0.01% | 1223 |
|
2018
Q1 | $189K | Buy |
+6,141
| New | +$189K | 0.01% | 1427 |
|